GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals
Clovis Oncology’s PARP Inhibitor Shines in Preliminary Prostate Cancer Trial
2021-04-12
Trials & Approvals
Immunocore’s Bispecific Cancer Therapy Impresses in Eye Cancer Trial
2021-04-10
Precision Medicine
Singapore Targets Widespread Implementation of Precision Medicine, Launches Phase II of its 10-Year Plan
2021-04-10
Trials & Approvals Cancer
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
Trials & Approvals Psychosis
Acadia Fumes Over FDA Rejection of its Psychosis Drug Nuplazid
2021-04-06
Trials & Approvals IONIS-PKK-LRx
Ionis’ Once-Monthly Treatment for Rare Hereditary Disease Achieves Trial Endpoints
2021-03-31
Trials & Approvals HOPE-B Trial
uniQure’s Inquiry Shows Hemophilia B Gene Therapy not Likely to Have Induced Liver Cancer
2021-03-30
Trials & Approvals
BMS, bluebird’s Multiple Myeloma Drug Becomes First BCMA Targeting CAR-T Therapy to Snag FDA Okay
2021-03-28
Trials & Approvals Frequency Therapeutics
Frequency Looks to Refocus After Sensorineural Hearing Loss Drug Suffers Setback
2021-03-27
Trials & Approvals RELATIVITY-047 Trial
BMS’s Combo Therapy Involving LAG-3 Drug Impresses in Melanoma Trial
2021-03-27
Trials & Approvals Anti-PD-1
Merck’s Anti-PD1 Therapy Receives Second FDA Approval for Esophageal Carcinoma
2021-03-25
Trials & Approvals Targeted Radioligand Therapy
Novartis’ Acquired Asset from Endocyte Shines in Phase 3 Prostate Cancer Trial
2021-03-24
R&D PD-1
Genentech Seeks FDA’s Blessings after Adjuvant Tecentriq Shows Promising Result in Lung Cancer Patients
2021-03-23
COVID-19
AstraZeneca’s COVID-19 Vaccine Shows 79% Efficacy in US Trial, Eyes FDA Approval
2021-03-22
CDMO
Fujifilm Plans a Cell Culture CDMO Site in North Carolina, Creating 700+ Job Opportunities
2021-03-22
1 … 29 30 31 32 33 … 50
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top